THE EFFICACY OF PEMETREXED-BASED TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC), AS CORRELATED WITH THE PATHOLOGIC FEATURES OF TUMORS

被引：0
|
作者：
Shiran, I. [1 ]
Borshteen, R. [1 ]
Urban, D. [1 ]
Onn, A. [1 ]
Biran, H. [1 ]
Bar, J. [1 ]
机构：
[1] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S45 / S46
页数：2
相关论文
共 50 条
  • [1] Pemetrexed-based chemotherapy in advanced nonsquamous non-small cell lung cancer (NSCLC).
    Alshehri, Abdulrahman Ali
    Alsubait, Saud Abdullrhman
    Alamgir, M. Ahsan
    Park, Chandler
    Wen, Sijin
    Luo, Jin
    Ma, Patrick
    Monga, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] A pemetrexed-based genetic study of Chinese Han patients with advanced non-small cell lung cancer (NSCLC).
    Lu, Shun
    Niu, Xiaomin
    Li, Ziming
    Yu, Yongfeng
    Ye, Xiangyun
    Liu, Yun
    Chen, Zhiwei
    Kan, Mengyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK plus Non-Small Cell Lung Cancer
    Jo, Jaemin
    Kim, Se Hyun
    Kim, Yu Jung
    Lee, Juhyun
    Kim, Miso
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    Chung, Jin-Haeng
    Jeon, Yoon Kyung
    Lee, Jong Seok
    YONSEI MEDICAL JOURNAL, 2018, 59 (02) : 202 - 210
  • [4] PEMETREXED MAINTENANCE TREATMENT IN ADVANCED NON SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Megaiz, Ahlem
    Bousahba, Abdelkader
    Rabah, Aicha
    Zemmour, Amel
    Ahed-Messaoud, Malika
    Ghazli, Soumia
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S588 - S589
  • [5] Pemetrexed for treatment of advanced non-small cell lung cancer
    Fossella, FV
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 100 - 105
  • [6] Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer
    Shaw, A. T.
    Varghese, A. M.
    Solomon, B. J.
    Costa, D. B.
    Novello, S.
    Mino-Kenudson, M.
    Awad, M. M.
    Engelman, J. A.
    Riely, G. J.
    Monica, V.
    Yeap, B. Y.
    Scagliotti, G. V.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 59 - 66
  • [7] Plasma Endoglin is Associated with Favorable Outcome for Pemetrexed-Based Therapy in Advanced Non-Small Cell Lung Cancer
    Li, Che-Hsing
    Ko, Jiunn-Liang
    Hsiao, Yu-Ping
    Tsai, Ming-Hung
    Lai, Yen-Chein
    Hsin, I-Lun
    Kang, Yu-Ting
    Sheu, Gwo-Tarng
    Lin, Wea-Lung
    Wu, Ming-Fang
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 9305 - 9318
  • [8] Association between TYMS Expression and Efficacy of Pemetrexed-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
    Wang, Ting
    Pan, Chang Chuan
    Yu, Jing Rui
    Long, Yu
    Cai, Xiao Hong
    Yin, Xu De
    Hao, Li Qiong
    Luo, Li Li
    PLOS ONE, 2013, 8 (09):
  • [9] Pemetrexed in advanced non-small cell lung cancer
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    Bareschino, Maria Anna
    Schettino, Clorinda
    Sacco, Paola Claudia
    Zeppa, Rosario
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (02) : 311 - 317
  • [10] THYMIDYLATE SYNTHASE (TS) MRNA AND PROTEIN EXPRESSION IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH PEMETREXED-BASED THERAPY.
    Monica, Valentina
    Novello, Silvia
    Milella, Michele
    Vavala', Tiziana
    Vari, Sabrina
    Lo Iacono, Marco
    Busso, Simone
    Fora, Gianluca
    Papotti, Mauro
    Scagliotti, Giorgio V.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1085 - S1085
12345